Skip to content

Risk Factors for Recurrence of Trigeminal Neuralgia After Percutaneous Balloon Compression

Development and Validation of a Machine Learning-Based Risk Prediction Model for Recurrence After Percutaneous Balloon Compression in Trigeminal Neuralgia Patients: A Retrospective Cohort Study

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07238244
Enrollment
700
Registered
2025-11-20
Start date
2025-12-15
Completion date
2026-03-15
Last updated
2025-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trigeminal Neuralgia

Keywords

Trigeminal Neuralgia, Percutaneous Balloon Compression, predication, Machine Learning Model

Brief summary

The goal of this observational study is to develop and validate a machine learning-based model for predicting pain recurrence risk after percutaneous balloon compression (PBC) in adult patients with primary trigeminal neuralgia (TN) who had their first PBC treatment. The main questions it aims to answer are: Can the machine learning-based model accurately predict pain recurrence after PBC in these primary TN patients? What key factors (like patient baseline traits, imaging parameters, surgical operation data) affect PBC post-operative pain recurrence? Do machine learning algorithms perform better than traditional Cox proportional hazards regression in predicting such recurrence? Participants (with existing PBC treatment records) will have their past data-including clinical info from the hospital's electronic medical record system, imaging data from the image archiving system, surgical data from the surgical anesthesia system, and follow-up data from the outpatient system-collected and analyzed to build and validate the prediction model.

Interventions

PROCEDUREPercutaneous Balloon Compression

The intervention studied is Percutaneous Balloon Compression (PBC). It is a minimally invasive surgical intervention used for the treatment of primary trigeminal neuralgia (TN), which involves percutaneously inserting a balloon to compress the trigeminal ganglion, aiming to relieve pain in patients with TN who are unresponsive to drug therapy or unable to tolerate drug adverse reactions.

Sponsors

Yueyang Hospital of Traditional Chinese Medicine
CollaboratorUNKNOWN
Second Xiangya Hospital of Central South University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Aged ≥ 18 years. 2. Meet the diagnostic criteria for primary trigeminal neuralgia according to the International Classification of Headache Disorders, 3rd edition (ICHD-3). 3. Undergo the first PBC treatment. 4. Have complete preoperative clinical data, imaging data, and intraoperative records. 5. Have at least one postoperative follow-up record available for determining the recurrence status.

Exclusion criteria

1. Secondary trigeminal neuralgia (e.g., caused by cerebellopontine angle tumors, multiple sclerosis, etc.). 2. Missing rate of key predictor variables (e.g., balloon shape) or outcome variables \> 15%. 3. Postoperative loss to follow-up (defined as no follow-up records available).

Design outcomes

Primary

MeasureTime frameDescription
Pain Recurrence After Percutaneous Balloon Compression in Patients with Primary Trigeminal Neuralgiathrough study completion, an average of 3 yearThe primary outcome measure focuses on whether pain recurrence occurs in patients with primary TN after their first PBC treatment, defined as a dichotomous variable (recurred or not recurred). Recurrence Criteria: Postoperative pain intensity, as assessed by the Barrow Neurological Institute Pain Intensity Score, rebounds to Grade IV (persistent pain controllable with medication) or Grade V (severe pain uncontrollable with medication), and this pain status persists for at least 1 week. Additionally, the recurrence must be accompanied by the need to increase the dose of pain medication or undergo reinterventional treatment (e.g., repeated PBC or other surgical procedures) to manage the pain.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026